Seelos Therapeutics Stock Buy Hold or Sell Recommendation
| SEEL Stock | USD 0.39 0.11 22.00% |
Given the investment horizon of 90 days and your conservative attitude towards risk, our recommendation regarding Seelos Therapeutics is 'Strong Sell'. The recommendation algorithm takes into account all of Seelos Therapeutics' available fundamental, technical, and predictive indicators you will find on this site.
Check out Seelos Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Seelos and provide practical buy, sell, or hold advice based on investors' constraints. Seelos Therapeutics. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in income.
Seelos |
Execute Seelos Therapeutics Buy or Sell Advice
The Seelos recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Seelos Therapeutics. Macroaxis does not own or have any residual interests in Seelos Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Seelos Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Moves totally opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Seelos Therapeutics Trading Alerts and Improvement Suggestions
| Seelos Therapeutics generated a negative expected return over the last 90 days | |
| Seelos Therapeutics has high historical volatility and very poor performance | |
| Seelos Therapeutics has some characteristics of a very speculative penny stock | |
| Seelos Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 2.2 M. Net Loss for the year was (37.88 M) with loss before overhead, payroll, taxes, and interest of (46.65 M). | |
| Seelos Therapeutics currently holds about 41.25 M in cash with (23.91 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.39. |
Seelos Therapeutics current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Seelos analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Seelos analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Seelos Therapeutics Returns Distribution Density
The distribution of Seelos Therapeutics' historical returns is an attempt to chart the uncertainty of Seelos Therapeutics' future price movements. The chart of the probability distribution of Seelos Therapeutics daily returns describes the distribution of returns around its average expected value. We use Seelos Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Seelos Therapeutics returns is essential to provide solid investment advice for Seelos Therapeutics.
| Mean Return | -3.37 | Value At Risk | -25 | Potential Upside | 13.18 | Standard Deviation | 13.13 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Seelos Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Seelos Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Seelos Therapeutics or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Seelos Therapeutics' price will be affected by overall otc stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Seelos otc's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -3.28 | |
β | Beta against Dow Jones | -0.9 | |
σ | Overall volatility | 13.80 | |
Ir | Information ratio | -0.27 |
Seelos Therapeutics Volatility Alert
Seelos Therapeutics is displaying above-average volatility over the selected time horizon. Seelos Therapeutics is a potential penny stock. Although Seelos Therapeutics may be in fact a good instrument to invest, many penny otc stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Seelos Therapeutics. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Seelos instrument if you perfectly time your entry and exit. However, remember that penny otcs that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Seelos Therapeutics Fundamentals Vs Peers
Comparing Seelos Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Seelos Therapeutics' direct or indirect competition across all of the common fundamentals between Seelos Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Seelos Therapeutics or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Seelos Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Seelos Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Seelos Therapeutics to competition |
| Fundamentals | Seelos Therapeutics | Peer Average |
| Return On Equity | -5.84 | -0.31 |
| Return On Asset | -2.61 | -0.14 |
| Profit Margin | 2.03 % | (1.27) % |
| Operating Margin | (8.35) % | (5.51) % |
| Current Valuation | 10.45 M | 16.62 B |
| Shares Outstanding | 581 K | 571.82 M |
| Shares Owned By Insiders | 0.49 % | 10.09 % |
| Shares Owned By Institutions | 4.46 % | 39.21 % |
| Number Of Shares Shorted | 170.89 K | 4.71 M |
| Price To Book | 15.10 X | 9.51 X |
| Price To Sales | 0.37 X | 11.42 X |
| Revenue | 2.2 M | 9.43 B |
| Gross Profit | (46.65 M) | 27.38 B |
| EBITDA | (40.44 M) | 3.9 B |
| Net Income | (37.88 M) | 570.98 M |
| Cash And Equivalents | 41.25 M | 2.7 B |
| Cash Per Share | 0.39 X | 5.01 X |
| Total Debt | 14.23 M | 5.32 B |
| Debt To Equity | 0.73 % | 48.70 % |
| Current Ratio | 3.60 X | 2.16 X |
| Book Value Per Share | (135.50) X | 1.93 K |
| Cash Flow From Operations | (23.91 M) | 971.22 M |
| Short Ratio | 0.14 X | 4.00 X |
| Earnings Per Share | 351.04 X | 3.12 X |
| Target Price | 120.0 | |
| Number Of Employees | 8 | 18.84 K |
| Beta | 1.85 | -0.15 |
| Market Capitalization | 743.68 K | 19.03 B |
| Total Asset | 5.42 M | 29.47 B |
| Retained Earnings | (252.63 M) | 9.33 B |
| Working Capital | (33.52 M) | 1.48 B |
| Net Asset | 5.42 M |
Note: Acquisition by Mehra Raj of 2282262 shares of Seelos Therapeutics at 1.08 subject to Rule 16b-3 [view details]
Seelos Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Seelos . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Seelos Therapeutics Buy or Sell Advice
When is the right time to buy or sell Seelos Therapeutics? Buying financial instruments such as Seelos OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Seelos Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Realty Funds Thematic Idea Now
Realty Funds
Funds or Etfs investing in real estate backed instruments or issues backed by different types of commercial properties. The Realty Funds theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Realty Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Seelos OTC Stock
Seelos Therapeutics financial ratios help investors to determine whether Seelos OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Seelos with respect to the benefits of owning Seelos Therapeutics security.